Education
About Us
Working with TipRanks
Follow Us
Bihua Chen Insider Profile
18 Followers
Bihua Chen, Former 10% Owner at MoonLake Immunotherapeutics, holds 1.99M shares in MoonLake Immunotherapeutics (Ticker: MLTX), holds 17.88M shares in BridgeBio Oncology Therapeutics (Ticker: BBOT), holds 3.57M shares in Biomea Fusion (Ticker: BMEA). Most recently, Bihua Chen Sold ― shares of MoonLake Immunotherapeutics on Oct 01, 2025 for an estimated value of $46.87M.
Bihua Chen MoonLake Immunotherapeutics (MLTX)Former 10% Owner
MoonLake Immunotherapeutics (MLTX)
Former 10% Owner
Ranked #72,866 out of 103,606 Corporate Insiders
Profitable Transactions
4 out of 14 Profitable Transactions
Average Return
-6.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bihua Chen holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 22, 2023 - Mar 22, 2024
Return:+144.70%
The most profitable trade made by Bihua Chen
Bihua Chen's Trading History
MoonLake Immunotherapeutics
Oct 01, 2025
Former 10% Owner
Informative Sell
46.87M
$14.08M
Biomea Fusion
Apr 03, 2023
Former Director
Informative Buy
12.00M
$7.46M
Erasca
Dec 20, 2022
Director
Informative Buy
2.00M
$23.90M
BridgeBio Oncology Therapeutics
Aug 13, 2025
Director, Ten Percent Owner
Uninformative Buy
155.38M
$215.08M
List of latest transactions for each holding click on a transaction to see Bihua Chen's performance on stock
You May Also Like
Bihua Chen insider profile FAQ
What is the percentage of profitable transactions made by Bihua Chen?
The percentage of profitable transactions made by Bihua Chen is 29%.
What is the average return per transaction made by Bihua Chen?
The average return per transaction made by Bihua Chen is -6.70%.
What stocks does Bihua Chen hold?
Bihua Chen holds: MLTX, BMEA, ERAS, BBOT stocks.
What was Bihua Chen’s latest transaction?
Bihua Chen latest transaction was an Informative Sell of $46.87M.
What was Bihua Chen's most profitable transaction?
Bihua Chen’s most profitable transaction was an Informative Buy of MLTX stock on March 22, 2023. The return on the trade was 144.70%.
What is Bihua Chen's role in MoonLake Immunotherapeutics?
Bihua Chen's role in MoonLake Immunotherapeutics is Former 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.